ArticleMovement disorders clinical practice2025
The Vodka Trial: Clinical and Genetic Characteristics of Alcohol Responsiveness in Laryngeal Dystonia.
Article in Movement disorders clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundLaryngeal dystonia (LD) is isolated task-specific focal dystonia, predominantly impairing speech production. Clinical observations and population survey studies have reported that up to 58% of patients with LD may have symptom improvement following alcohol intake.
objectivesTo determine the objective characteristics of alcohol responsiveness in LD using a standardized alcohol challenge test and genetic testing.
methodsA total of 109 patients with isolated focal LD participated in the study. Patients were administered two non-diluted drinks of 40-proof vodka 30 min apart, followed by assessments of voice symptoms, breath alcohol content, and side effects. Patients were considered alcohol-responsive (EtOH+) if their symptoms changed by ≥10% from baseline. Whole-exome sequencing was performed to identify genetic variants associated with the alcohol responsiveness of LD.
resultsAll patients tolerated the standardized alcohol challenge test without major adverse events. Fifty-two patients (47.7%) had an average of 44.4 ± 25.0% improvement of LD symptoms about 45 min after alcohol intake. Five genetic variants in GABAergic pathway-related genes were enriched in EtOH+ patients, and two of these, rs11644926 (ADCY7) and rs2230741 (ADCY9), were associated with the improvement of dystonic voice symptoms.
conclusionsAlcohol responsiveness of LD symptoms is a robust feature related to the genes regulating the GABAergic synapses. This finding provides support for the evaluation of novel oral medications with mechanisms of action similar to alcohol for the treatment of patients with alcohol-responsive dystonia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.